Skip to content
healthcare.dev

BENZTROPINE MESYLATE

NDC 10135-814, benztropine mesylate, tablet, from Marlex PHARMACEUTICAL, INC.

Product NDC
10135-814
Status
Listed
Labeler
Marlex PHARMACEUTICAL, INC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204713
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZTROPINE MESYLATE1 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Antihistamine [EPC]; Cholinergic Antagonists [MoA]; Histamine Receptor Antagonists [MoA]

Package NDCNDC-11Package
10135-814-0110135081401100 TABLET in 1 BOTTLE (10135-814-01)
10135-814-10101350814101000 TABLET in 1 BOTTLE (10135-814-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31bbcbfa-dc74-99e2-e063-6394a90aa608

Use it

Look up 10135-814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.